Evidence map›Paper›PMID 32017483›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2020

Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands.

Christopher R Manzella, Max Ackerman, Megha Singhal, Alexander L Ticho, Justin Ceh, Waddah A Alrefai, Seema Saksena, Pradeep K Dudeja, Ravinder K Gill

Open access · goldAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. AHR in the intestinal microenvironment: safeguarding barrier function.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher R ManzellaDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.
Max AckermanDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Megha SinghalDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Alexander L TichoDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.
Justin CehDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Waddah A AlrefaiDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Seema SaksenaDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Pradeep K DudejaDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
Ravinder K GillDivision of Gastroenterology & Hepatology, University of Illinois at Chicago, Chicago, IL, USA, rgill@uic.edu.
University of Illinois Chicago · USJesse Brown VA Medical Center · US

Funding

Intestinal Anion Transporters: Function and RegulationR01DK054016 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEJA, PRADEEP K · 1998 to 2022
$7.0M
Transporter Trafficking Mechanisms in Infectious DiarrheaR01DK092441 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEJA, PRADEEP K · 2011 to 2020
$3.0M
Intestinal 5-HT Transporter: A novel therapeutic target for GI disordersR01DK098170 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GILL, RAVINDER K · 2014 to 2022
$3.0M
Probiotics:Potential Therapeutic Roles in DiarrheaR01DK081858 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEJA, PRADEEP K · 2008 to 2017
$2.5M
Gut-liver crosstalk in bile-acid induced diarrheaR01DK109709 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALREFAI, WADDAH A. · 2016 to 2019
$1.1M
Novel role of serotonin in AhR dependent pathways in intestineF30DK113703 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MANZELLA, CHRISTOPHER ROBERT · 2017 to 2020
$199k
Epigenetic regulation of bile acids in health and diseaseF30DK117535 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI TICHO, ALEXANDER LOUIS · 2018 to 2020
$150k
BLRD Research Career Scientist Award ApplicationIK6BX005243 · VA · JESSE BROWN VA MEDICAL CENTER · PI ALREFAI, WADDAH A. · 2020 to 2025
–
Regulation of Intestinal Sodium Absorption in Health and DiseaseI01BX002867 · VA · JESSE BROWN VA MEDICAL CENTER · PI Seema Saksena · 2016 to 2026
–
BLRD VA I01 BX000152BLRD VA I01 BX002011BLRD VA I01 BX002867BLRD VA IK6 BX005243Crohn's and Colitis Foundation (CCFA) 581138National Institutes of Health/ National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) R01 DK098170, R01 DK54016, R01 DK81858, R01 DK92441, R01 DK109709, F30 DK113703NIDDK NIH HHS F30 DK113703NIDDK NIH HHS F30 DK117535NIDDK NIH HHS R01 DK054016NIDDK NIH HHS R01 DK081858NIDDK NIH HHS R01 DK092441NIDDK NIH HHS R01 DK098170NIDDK NIH HHS R01 DK109709VA BX 002011, BX 002867, BX 000152, VA RCS Award, VA SRCS Award
6 · The paper itself

Abstract

BACKGROUND/

aimsSerotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter and hormone with important physiological functions in many organs, including the intestine. We have previously shown that 5-HT activates the aryl hydrocarbon receptor (AhR) in intestinal epithelial cells (IECs) via a serotonin transporter (SERT)-dependent mechanism. AhR is a nuclear receptor that binds a variety of molecules including tryptophan (TRP) metabolites to regulate physiological processes in the intestine including xenobiotic detoxification and immune modulation. We hypothesized that 5-HT activates AhR indirectly by interfering with metabolic clearance of AhR ligands by cytochrome P450 1A1 (CYP1A1).

methodsInhibition of CYP1A1 activity by 5-HT was assessed in the human intestinal epithelial cell line Caco-2 and recombinant CYP1A1 microsomes using both luciferase and LC-MS/MS. Degradation of 5-HT by recombinant CYP1A1 was measured by LC-MS/MS. For in vitro studies, CYP1A1 and CYP1B1 mRNA expression levels were measured by RT-PCR and CYP1A1 activity was measured by ethoxyresorufin-O-deethylase (EROD) assays. For in vivo studies, AhR ligands were administered to SERT KO mice and WT littermates and intestinal mucosa CYP1A1 mRNA was measured.

resultsWe show that 5-HT inhibits metabolism of both the pro-luciferin CYP1A1 substrate Luc-CEE as well as the high affinity AhR ligand 6-formylindolo[3,2-b] carbazole (FICZ). Recombinant CYP1A1 assays revealed that 5-HT is metabolized by CYP1A1 in an NADPH dependent manner. Treatment with 5-HT in TRP-free medium, which is devoid of trace AhR ligands, showed that 5-HT requires the presence of AhR ligands to activate AhR. Cotreatment with 5-HT and FICZ confirmed that 5-HT potentiates induction of AhR target genes by AhR ligands. However, this was only true for ligands which are CYP1A1 substrates such as FICZ. Administration of β-napthoflavone by gavage or indole-3-carbinol via diet to SERT KO mice revealed that lack of SERT impairs intestinal AhR activation.

conclusionOur studies provide novel evidence of crosstalk between serotonergic and AhR signaling where 5-HT can influence the ability of AhR ligands to activate the receptor in the intestine.

Indexed as

Animalsbeta-NaphthoflavoneCaco-2 CellsCarbazolesCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1HumansLigandsMaleMiceMice, KnockoutReceptors, Aryl HydrocarbonRecombinant ProteinsRNA, MessengerSerotoninSerotonin Plasma Membrane Transport Proteins6-formylindolo(3,2-b)carbazolebeta-NaphthoflavoneCarbazolesCYP1A1 protein, humanCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1LigandsReceptors, Aryl HydrocarbonRecombinant ProteinsRNA, MessengerSerotoninSerotonin Plasma Membrane Transport ProteinsSlc6a4 protein, mouseSerotonin (5-HT); Cytochrome P450 1A1 (CYP1A1); Aryl hydrocarbon receptor (AhR)

Identifiers

PMID32017483
PMCPMC7050772
OpenAlexW3007055930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.